Clinical Trial Update: Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320 [Phase 2]

View source ↗

Summary

Phase 2 rollover study evaluating indinavir combined with nucleoside analogs in HIV-infected subjects, reporting treatment success and failure outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Indinavir (indinavir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED